Galliford Try is currently the highest yielding housebuilder with a dividend yield of 8%. That’s a very high yield, but is it enough to offset the risks of this notoriously cyclical industry? Neil Woodford’s team certainly seem to think UK … [Read more...] about Is Galliford Try’s 8% dividend yield enough to offset the risks?
Yesterday I published my investment performance review for 2017 and in it I mentioned my portfolio's one-year performance since the start of 2017. That was a mistake. Maynard Paton pointed out that in my 2016 year-end review I said this: To be … [Read more...] about Why one-year investment performance is a terrible metric
2017 was another year of above average investment returns in what is now a very old bull market. As with previous year-end reviews, I’ll review my model portfolio’s performance against its various goals as well as the performance of the individual … [Read more...] about My investment performance in 2017: A very long review
When I switched from “deep value” to “defensive value” investing in 2011, the first stock I purchased with the new approach was BP. Six volatile years later, this has turned out to be a mildly disappointing investment. That’s partly because of … [Read more...] about I’m selling BP because of its high debts and uncertain future
2017 is drawing to a close. I've already published my year-end FTSE 100 and FTSE 250 market reviews, so now it's time to round up the most popular blog posts of the year. These are the blog posts that attracted the highest number of comments … [Read more...] about 10 Most popular UK Value Investor blog posts of 2017
As regular readers will know, I think many low-risk defensive "bond proxy" stocks are probably too expensive. Although I usually only talk about UK stocks, I thought I would take a look at two high profile examples of the bond proxy genre from … [Read more...] about Is Buffett right to choose Coca Cola over Microsoft?
Over the last 20 years, the performance gap between the FTSE 250 and FTSE 100 has been enormous. While the FTSE 100 has spent most of the last 20 years failing to beat its dot-com peak, the FTSE 250 has raced ahead. In fact it's now almost three … [Read more...] about FTSE 250 Valuation and forecast for 2018 and beyond
2017 is drawing to a close, so once again it's time for my semi-regular UK stock market review. In this case I'll be looking at the FTSE 100's current valuation and making a fact-based forecast for 2018. I'll also use that same approach to make a … [Read more...] about FTSE 100 Valuation and forecast for 2018 and beyond
Reckitt Benckiser is a name which came up several times following my recent, mildly negative review of Unilever. In many ways, Reckitt Benckiser is in the same boat as Unilever. They’re both companies which are highly valued because of their … [Read more...] about Reckitt Benckiser: Expensive defensive or high debt, low growth timebomb?
Trustworthy dividend stocks are hard to find. Yes, you could look at Unilever, Reckitt Benckiser, or any of the other "bond proxies" which dividend investors are so in love with. But those stocks are mostly expensive and personally I want to … [Read more...] about Hunting for trustworthy dividend stocks